Tactile Systems Technology, Inc. Sales-type Lease, Revenue
Tactile Systems Technology, Inc. (TCMD) reported Sales-type Lease, Revenue of $9.21 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SalesTypeLeaseRevenue · last filed 2026-08-10
- Tactile Systems Technology, Inc. sales-type lease, revenue for the quarter ending 2026-06-30 was $9.21M, a 9.97% increase year-over-year.
- Tactile Systems Technology, Inc. sales-type lease, revenue for the quarter ending 2026-03-31 was $8.30M, a 5.66% decline year-over-year.
- Tactile Systems Technology, Inc. sales-type lease, revenue for the quarter ending 2025-12-31 was $10.89M, a 5.58% increase year-over-year.
- Tactile Systems Technology, Inc. sales-type lease, revenue for the quarter ending 2025-09-30 was $8.87M, a 10.68% decline year-over-year.
- Tactile Systems Technology, Inc. sales-type lease, revenue for fiscal 2025 was $36.93M, a 0.12% decline from fiscal 2024.
- Tactile Systems Technology, Inc. sales-type lease, revenue for fiscal 2024 was $36.97M, a 5.85% increase from fiscal 2023.
- Tactile Systems Technology, Inc. sales-type lease, revenue for fiscal 2023 was $34.93M, a 1.44% decline from fiscal 2022.
- Tactile Systems Technology, Inc. sales-type lease, revenue for fiscal 2022 was $35.44M, a 17.57% increase from fiscal 2021.
| Period end | Sales-type Lease, Revenue 3 month | Sales-type Lease, Revenue 6 month | Sales-type Lease, Revenue 9 month | Sales-type Lease, Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | $9.21M 10-Q · filed 2026-08-10 | $17.51M 10-Q · filed 2026-08-10 | $28.40M derived: sum of 3 quarters · filed 2026-08-10 | $37.27M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $8.30M 10-Q · filed 2026-05-04 | $19.19M derived: sum of 2 quarters · filed 2026-05-04 | $28.06M derived: sum of 3 quarters · filed 2026-05-04 | $36.43M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $10.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $19.76M derived: sum of 2 quarters · filed 2026-02-17 | $28.13M derived: sum of 3 quarters · filed 2026-08-10 | $36.93M 10-K · filed 2026-02-17 |
| 2025-09-30 | $8.87M 10-Q · filed 2025-11-03 | $17.24M derived: sum of 2 quarters · filed 2026-08-10 | $26.04M 10-Q · filed 2025-11-03 | $36.35M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $8.37M 10-Q · filed 2026-08-10 | $17.17M 10-Q · filed 2026-08-10 | $27.49M derived: sum of 3 quarters · filed 2026-08-10 | $37.41M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $8.80M 10-Q · filed 2026-05-04 | $19.11M derived: sum of 2 quarters · filed 2026-05-04 | $29.04M derived: sum of 3 quarters · filed 2026-05-04 | $37.99M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $10.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $20.24M derived: sum of 2 quarters · filed 2026-02-17 | $29.19M derived: sum of 3 quarters · filed 2026-02-17 | $36.97M 10-K · filed 2026-02-17 |
| 2024-09-30 | $9.93M 10-Q · filed 2025-11-03 | $18.88M derived: sum of 2 quarters · filed 2025-11-03 | $26.66M 10-Q · filed 2025-11-03 | $36.27M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $8.95M 10-Q · filed 2025-08-04 | $16.73M 10-Q · filed 2025-08-04 | $26.35M derived: sum of 3 quarters · filed 2026-02-17 | $37.07M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $7.78M 10-Q · filed 2025-05-05 | $17.40M derived: sum of 2 quarters · filed 2026-02-17 | $28.12M derived: sum of 3 quarters · filed 2026-02-17 | $36.66M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $9.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $20.34M derived: sum of 2 quarters · filed 2026-02-17 | $28.88M derived: sum of 3 quarters · filed 2026-02-17 | $34.93M 10-K · filed 2026-02-17 |
| 2023-09-30 | $10.72M 10-Q · filed 2024-11-04 | $19.26M derived: sum of 2 quarters · filed 2024-11-04 | $25.31M 10-Q · filed 2024-11-04 | $35.85M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $8.54M 10-Q · filed 2024-08-05 | $14.59M 10-Q · filed 2024-08-05 | $25.13M derived: sum of 3 quarters · filed 2025-02-18 | $34.84M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $6.05M 10-Q · filed 2024-05-06 | $16.59M derived: sum of 2 quarters · filed 2025-02-18 | $26.31M derived: sum of 3 quarters · filed 2025-02-18 | $34.69M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $10.54M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $20.25M derived: sum of 2 quarters · filed 2025-02-18 | $28.63M derived: sum of 3 quarters · filed 2025-02-18 | $35.44M 10-K · filed 2025-02-18 |
| 2022-09-30 | $9.72M 10-Q · filed 2023-11-06 | $18.10M derived: sum of 2 quarters · filed 2023-11-06 | $24.91M 10-Q · filed 2023-11-06 | $32.93M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | $8.38M 10-Q · filed 2023-08-07 | $15.19M 10-Q · filed 2023-08-07 | $23.22M derived: sum of 3 quarters · filed 2024-02-20 | $31.25M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | $6.81M 10-Q · filed 2023-05-08 | $14.84M derived: sum of 2 quarters · filed 2024-02-20 | $22.87M derived: sum of 3 quarters · filed 2024-02-20 | $30.30M derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | $8.03M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $16.07M derived: sum of 2 quarters · filed 2024-02-20 | $23.50M derived: sum of 3 quarters · filed 2024-02-20 | $30.14M 10-K · filed 2024-02-20 |
| 2021-09-30 | $8.04M 10-Q · filed 2022-11-07 | $15.47M derived: sum of 2 quarters · filed 2022-11-07 | $22.11M 10-Q · filed 2022-11-07 | $29.57M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $7.43M 10-Q · filed 2022-08-01 | $14.08M 10-Q · filed 2022-08-01 | $21.54M derived: sum of 3 quarters · filed 2023-02-21 | $28.06M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $6.65M 10-Q · filed 2022-05-02 | $14.11M derived: sum of 2 quarters · filed 2023-02-21 | $20.63M derived: sum of 3 quarters · filed 2023-02-21 | $26.23M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | $7.46M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $13.98M derived: sum of 2 quarters · filed 2023-02-21 | $19.58M derived: sum of 3 quarters · filed 2023-02-21 | $25.63M 10-K · filed 2023-02-21 |
| 2020-09-30 | $6.52M 10-Q · filed 2021-11-08 | $12.12M derived: sum of 2 quarters · filed 2021-11-08 | $18.17M 10-Q · filed 2021-11-08 | $24.66M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-06-30 | $5.60M 10-Q · filed 2021-08-02 | $11.65M 10-Q · filed 2021-08-02 | $18.14M derived: sum of 3 quarters · filed 2022-02-23 | $24.22M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-03-31 | $6.05M 10-Q · filed 2021-05-03 | $12.53M derived: sum of 2 quarters · filed 2022-02-23 | $18.62M derived: sum of 3 quarters · filed 2022-02-23 | $23.66M derived: sum of 4 quarters · filed 2022-02-23 |
| 2019-12-31 | $6.48M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $12.57M derived: sum of 2 quarters · filed 2022-02-23 | $17.61M derived: sum of 3 quarters · filed 2022-02-23 | $21.57M 10-K · filed 2022-02-23 |
| 2019-09-30 | $6.09M 10-Q · filed 2020-11-02 | $11.12M derived: sum of 2 quarters · filed 2020-11-02 | $15.09M 10-Q · filed 2020-11-02 | |
| 2019-06-30 | $5.04M 10-Q · filed 2020-08-03 | $9.00M 10-Q · filed 2020-08-03 | ||
| 2019-03-31 | $3.96M 10-Q · filed 2020-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B |